Phase II Trial of SBRT and Hormone Therapy for Oligometastases in Prostate Cancer

被引：2

作者：

Conde-Moreno, A. J. ^{[1
]}

Lopez, F. ^{[2
]}

Hervas, A. ^{[2
]}

Piquer Camanes, T. ^{[3
]}

Mendez, A. ^{[4
]}

Puertas, M. D. M. ^{[5
]}

Valero, J. J. ^{[6
]}

Gomez Iturriaga, A. ^{[7
]}

Rico, M. ^{[8
]}

Vazquez de la Torre, M. L. ^{[9
]}

Samper Ots, P. M. ^{[10
]}

Perez Romasanta, L. A. ^{[11
]}

Pastor Peidro, J. ^{[12
]}

Ibanez, C. ^{[13
]}

Ferrer, F. ^{[14
]}

Porras-Martinez, M. ^{[15
]}

Zapatero, A. ^{[16
]}

Garcia Blanco, A. S. ^{[17
]}

Rodriguez, A. ^{[18
]}

Ferrer, C. ^{[19
]}

机构：

[1] Hosp Univ & Politecn La Fe, Valencia, Spain

[2] Hosp Univ Ramon y Cajal, Madrid, Spain

[3] Consorcio Hosp Prov Castellon, Castellon de La Plana, Spain

[4] Miguel Servet Univ Hosp, Zaragoza, Spain

[5] Hosp Miguel Servet, Zaragoza, Spain

[6] Univ Hosp HM Sanchinarro Puerta del Sur, Madrid, Spain

[7] Cruces Univ Hosp, Baracaldo, Spain

[8] Complejo Hosp Navarra, Pamplona, Spain

[9] Hosp Meixoeiro, Vigo, Spain

[10] Hosp Univ Rey Juan Carlos, Madrid, Spain

[11] Hosp Clin Salamanca, Salamanca, Spain

[12] Hosp Gen Valencia, Valencia, Spain

[13] Hosp Cent Def Gomez Ulla, Madrid, Spain

[14] Catalan Inst Oncol, Dept Radiat Oncol, Lhospitalet Barcelona, Spain

[15] Hosp Univ Virgen de la Arrixaca, Murcia, Spain

[16] Hosp Univ La Princesa, Madrid, Spain

[17] Hosp Univ Marques de Valdecilla, Santander, Spain

[18] Hosp Ruber, Madrid, Spain

[19] Hosp Prov Castellon, Castellon de La Plana, Spain

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期

关键词：

D O I：

10.1016/j.ijrobp.2019.06.155

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1075

引用

页码：S149 / S150

页数：2

共 50 条

[21] Oligometastases from Prostate Cancer: local treatment with stereotactic body radiotherapy (SBRT)
Habl, G.
Straube, C.
Duma, M. N.
Oechsner, M.
Kessel, K. A.
Gschwend, J. E.
Combs, S. E.
STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 : S69 - S70
[22] Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
Gregor Habl
Christoph Straube
Kilian Schiller
Marciana Nona Duma
Markus Oechsner
Kerstin A. Kessel
Matthias Eiber
Markus Schwaiger
Hubert Kübler
Jürgen E. Gschwend
Stephanie E. Combs
BMC Cancer, 17
[23] Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
Habl, Gregor
Straube, Christoph
Schiller, Kilian
Duma, Marciana Nona
Oechsner, Markus
Kessel, Kerstin A.
Eiber, Matthias
Schwaiger, Markus
Kuebler, Hubert
Gschwend, Juergen E.
Combs, Stephanie E.
BMC CANCER, 2017, 17
[24] PHASE II TRIAL OF 4'-DEOXYDOXORUBICIN (ESORUBICIN) IN HORMONE RESISTANT PROSTATE-CANCER
BRAICH, T
AHMANN, FR
GAREWAL, HS
ROBERTONE, A
SALMON, SE
INVESTIGATIONAL NEW DRUGS, 1986, 4 (02) : 193 - 196
[25] A phase II trial of deferoxamine in patients with hormone-refractory metastatic prostate cancer
Dreicer, R
Kemp, JD
Stegink, LD
Cardillo, T
Davis, CS
Forest, PK
See, WA
CANCER INVESTIGATION, 1997, 15 (04) : 311 - 317
[26] A phase II trial of oral estramustine and oral etoposide in hormone refractory prostate cancer
Pienta, KJ
Redman, BG
Bandekar, R
Strawderman, M
Cease, K
Esper, PS
Naik, H
Smith, DC
UROLOGY, 1997, 50 (03) : 401 - 406
[27] Phase II trial investigating the effects of zoledronate and dexamethasone in hormone resistant prostate cancer
Din, O.
Horsman, J.
James, N.
Wood, K.
Kirkbride, P.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[28] A phase II trial of docetaxel and vinorelbine in patients with hormone-refractory prostate cancer
Goodin, S
Rao, KV
Kane, M
Dave, N
Capanna, T
Doyle-Lindrud, S
Engle, E
Jin, LX
Todd, M
DiPaola, RS
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (02) : 199 - 204
[29] A phase II trial of docetaxel and vinorelbine in patients with hormone-refractory prostate cancer
Susan Goodin
Kamakshi V. Rao
Michael Kane
Nisha Dave
Terry Capanna
Susan Doyle-Lindrud
Elizabeth Engle
Lixian Jin
Mary Todd
Robert S. DiPaola
Cancer Chemotherapy and Pharmacology, 2005, 56 : 199 - 204
[30] Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer (EXTEND): A Multicenter, Randomized Phase II Trial
Tang, C.
Sherry, A. D.
Haymaker, C.
Bathala, T.
Liu, S.
Fellman, B.
Aparicio, A.
Zurita-Saavedra, A.
Chun, S.
Reddy, J.
Efstathiou, E.
Wang, J.
Pilie, P.
Reuben, A.
Kovitz, C.
Kumar, R.
Chapin, B.
Gomez, D. R.
Wistuba, I.
Corn, P. G.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (05): : 1059 - 1060

← 1 2 3 4 5 →